Last reviewed · How we verify

NCT05847062

Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.

Status unknown NA Last updated 6 May 2023
What this trial tests

NA trial testing reverse shoulder arthroplasty in Rotator Cuff Arthropathy in 42 participants. Status unknown.

Timeline
8 March 2022
Primary endpoint
1 March 2025
31 December 2025

Quick facts

Lead sponsorYaiza Lopiz Morales
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment42
Start date8 March 2022
Primary completion1 March 2025
Estimated completion31 December 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Yaiza Lopiz Morales

Who can join

65 and older, any sex, with Rotator Cuff Arthropathy or Glenohumeral Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the functional outcomes, complications and muscle performance by isokinetic study of two reverse arthroplasty systems (one with medialized center of rotation and the other with lateralized center of rotation) in the treatment of rotator cuff arthropathies or irreparable cuff tears.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of reverse shoulder arthroplasty

Trials testing the same drug.

Other recruiting trials for Rotator Cuff Arthropathy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing